World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
10431
World Ranking
4753
National Ranking
2136

Overview

Howard M. Lederman is affiliated with Johns Hopkins University in the United States. Their research spans multiple fields with a strong focus on biochemistry, genetics, molecular biology, and medicine. Within these broad areas, Lederman's work specializes in molecular biology, immunology, cancer research, pulmonary and respiratory medicine, and infectious diseases.

The primary scientific topics addressed in Lederman's research include DNA repair mechanisms, carcinogens and genotoxicity assessment, immunodeficiency and autoimmune disorders, genetic neurodegenerative diseases, radiation therapy and dosimetry, as well as SARS-CoV-2 and COVID-19 research. This range reflects a multidisciplinary approach to understanding disease mechanisms at genetic and molecular levels, particularly related to immune function and genetic disorders.

Lederman has contributed to several peer-reviewed papers in notable journals, including the following recent publications:

  • "DNA methylation and gene expression signatures are associated with ataxia-telangiectasia phenotype," 2020, Scientific Reports
  • "Multidisciplinary Management of Ataxia Telangiectasia: Current Perspectives," 2021, Journal of Multidisciplinary Healthcare
  • "Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients," 2022, Open Forum Infectious Diseases
  • "Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk children," 2021, JCI Insight
  • "Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial," 2024, The Lancet Neurology

Frequent collaborators include Sharon A. McGrath-Morrow, Jennifer Wright, Valerie Natale, Cynthia Rothblum-Oviatt, and Thomas O. Crawford. These professional associations highlight ongoing partnerships in the fields of immunology and clinical research related to rare diseases and genetic disorders.

Lederman publishes regularly in several specialized journals with repeated contributions to the Journal of Allergy and Clinical Immunology, Orphanet Journal of Rare Diseases, Clinical Immunology, Journal of Clinical Immunology, and Research Square. This indicates a consistent engagement with communities focused on immunology, rare disease research, and clinical applications.

Best Publications

  • JM2, encoding a fork head–related protein, is mutated in X-linked autoimmunity–allergic disregulation syndrome

    Talal A. Chatila;Frank Blaeser;Nga Ho;Howard M. Lederman

  • Ataxia telangiectasia: a review

    Cynthia Rothblum-Oviatt;Jennifer Wright;Maureen A. Lefton-Greif;Sharon A. McGrath-Morrow

  • X-linked agammaglobulinemia: report on a United States registry of 201 patients.

    Jerry A. Winkelstein;Mary C. Marino;Howard M. Lederman;Stacie M. Jones

  • X-linked agammaglobulinemia: an analysis of 96 patients.

    Howard M. Lederman;Jerry A. Winkelstein

  • An essential role for BLNK in human B cell development.

    Yoshiyuki Minegishi;Jurg Rohrer;Elaine Coustan-Smith;Howard M. Lederman

  • Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1

    Raphael P. Viscidi;Kumudini Mayur;Howard M. Lederman;Alan D. Frankel

  • Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review.

    Jason A. Daniels;Howard M. Lederman;Anirban Maitra;Elizabeth A. Montgomery

  • Immunodeficiency and infections in ataxia-telangiectasia.

    Anna Nowak-Wegrzyn;Thomas O Crawford;Jerry A Winkelstein;Kathryn A Carson

  • Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature.

    Mary Beth Fasano;Kathleen E. Sullivan;Kathleen E. Sullivan;Sampson B. Sarpong;Sampson B. Sarpong;Robert A. Wood

  • Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen

    Hernan Valdez;Kimberly Y. Smith;Alan Landay;Elizabeth Connick

  • Overview of Infections in the Immunocompromised Host.

    Lesia K. Dropulic;Howard M. Lederman

  • Increased susceptibility to mycoplasma infection in patients with hypogammaglobulinemia

    Chaim M. Roifman;C. Pandu Rao;Howard M. Lederman;Sasson Lavi

  • Survival probability in ataxia telangiectasia

    Thomas O. Crawford;R. L. Skolasky;R. Fernandez;K. J. Rosquist

  • Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts

    William T. Shearer;Thomas A. Fleisher;Rebecca H. Buckley;Zuhair Ballas

  • Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency.

    Mary E. Bollinger;Francisco X. Arredondo-Vega;Ines Santisteban;Kathleen Schwarz

  • Adenosine Deaminase Deficiency in Adults

    Hulya Ozsahin;Francisco X. Arredondo-Vega;Ines Santisteban;Hanspeter Fuhrer

  • Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 among infants with sickle cell disease

    Katherine L. O'Brien;Andrea J. Swift;Jerry A. Winkelstein;Mathuram Santosham

  • Ataxia-telangiectasia (A-T): An emerging dimension of premature ageing.

    Yosef Shiloh;Howard M. Lederman

  • Incomplete Immune Reconstitution after Initiation of Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Patients with Severe CD4+ Cell Depletion

    Howard M. Lederman;Paige L. Williams;Julia W. Wu;Thomas G. Evans

  • Cryptosporidiosis Stimulates an Inflammatory Intestinal Response in Malnourished Haitian Children

    Beth D. Kirkpatrick;Michelle M. Daniels;Simone Sonia Jean;Jean W. Pape

Frequent Co-Authors

Jerry A. Winkelstein
Jerry A. Winkelstein Johns Hopkins University School of Medicine
Anna Nowak-Wegrzyn
Anna Nowak-Wegrzyn New York University
Kathleen E. Sullivan
Kathleen E. Sullivan Children's Hospital of Philadelphia
Paige L. Williams
Paige L. Williams Harvard University
Bradley A. Warady
Bradley A. Warady Children's Mercy Hospital
Michael S. Hershfield
Michael S. Hershfield Duke University
J. Allen McCutchan
J. Allen McCutchan University of California, San Diego
Judith S. Currier
Judith S. Currier University of California, Los Angeles
Diane R. Gold
Diane R. Gold Harvard University
Mary Ellen Conley
Mary Ellen Conley Rockefeller University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career opportunities in healthcare and research. Transitioning roles within nursing, such as moving from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (NP), offers specialization options for professionals aiming to deepen their clinical skills. Resources on how to transition from fnp to acute care np provide valuable guidance for this pathway.

Accelerated nursing programs are particularly popular among students who hold degrees in other fields but want to enter nursing quickly. Several reputable accelerated options exist, including the highly recommended accelerated fnp programs designed for swift advancement to nurse practitioner roles.

Additionally, individuals without prior nursing experience can explore online accelerated nursing programs for non nurses, which allow them to gain necessary credentials efficiently while balancing other commitments.

For those seeking a less competitive entry into nursing education, some of the easiest accelerated nursing programs provide accessible pathways without compromising quality. These programs can be strategic stepping stones toward careers that intersect with immunology research and clinical practice.

Best Scientists Citing Howard M. Lederman

Trending Scientists